Browsing eNauka

Browsing by Author Dubinsky P.

Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)TypeМp-cat.
2022Concurrent weekly cisplatin and simultaneous integrated boost intensity-modulated radiotherapy of locally advanced squamous cell carcinoma of the head and neckDubinsky P.; Jeremic B.; Svajdova M.; Barilíková G.; Matula P.; Nadzonová D.; Vojtek V.Naučni članak
Mp kategorija će biti prikazana naknadno.
2022Human Papillomavirus-Related Non-Metastatic Oropharyngeal Carcinoma: Current Local Treatment Options and Future PerspectivesSvajdova M.; Dubinsky P.; Kazda T.; Jeremic, BranislavNaučna kritika i polemika
21M21 - Vodeći međunarodni časopis kategorije M21
2018Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC– Ain't no mountain high enough…. to keep me getting to youJeremic B.; Caamaño A.; Dubinsky P.; Cihoric N.; Igrutinovic I.; Videtic G.Informativni prilog
21aM21a - Vodeći međunarodni časopis kategorije M21a
2015No Role For Trimodality Therapy And Consolidation Chemotherapy When Compared To Concurrent Radiochemotherapy Alone In Stage III Nonsmall Cell Lung CancerJeremić, Branislav ; Cihoric C.; Casas F.; Gomez-Caamano A.; Dubinsky P.Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2021Novel technological aspects of radiation therapy in head and neck cancerJeremic B.; Kiladze I.; Ozyigit, Gokhan; Filipovic, Nenad  ; Dubinsky P.Naučna kritika i polemika
23M23 - Međunarodni časopis kategorije M23
2021Systemic therapy in recurrent or metastatic squamous cell head and neck cancerKiladze I.; Ozyigit, Gokhan; Dubinsky P.; Filipovic, Nenad  ; Jeremic B.Naučni članak
23M23 - Međunarodni časopis kategorije M23
2018Treatment-related predictive and prognostic factors in trimodality approach in stage IIIA/N2 non-small cell lung cancerJeremic, Branislav; Casas F.; Dubinsky P.; Gómez-Caamano A.; Cihoric N.; Videtic G.; Igrutinovic I.Naučna kritika i polemika
21M21 - Vodeći međunarodni časopis kategorije M21
2015Trimodality treatment approach in stage III/pN2 nonsmall cell lung cancer. 'Usually appropriate' may well be very inappropriate treatment optionJeremić, Branislav ; Casas F.; Dubinsky P.; Cihoric N.; Gomez-Caamano A.Article
22M22